ArticleInternational journal of cancer2019

PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer.

Yu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.